Q Gao1, M Niti, L Feng, K B Yap, Tze Pin Ng. 1. Gerontological Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Abstract
OBJECTIVE: To determine the association between long chain omega-3 polyunsaturated fatty acid (n-3 PUFA) supplements intake and cognitive decline in an older Chinese population. DESIGN: Prospective cohort study. SETTING: The Singapore Longitudinal Aging Studies (SLAS), a community-based study in urban region of Singapore. PARTICIPANTS: 1,475 Chinese adults aged ≥ 55 years. MEASUREMENT: Omega-3 PUFA supplements intake and Mini-Mental State Examination (MMSE) were assessed at baseline. MMSE was re-assessed at a median of 1.5 years after baseline and cognitive decline was defined as at least 2-points drop in MMSE score from baseline to follow-up. Odds ratios (ORs) of association between n-3 PUFA supplements intake and cognitive decline were calculated in logistic regression models controlling for baseline confounding variables. RESULTS: Daily n-3 PUFA supplements intake was significantly (p=0.024) associated with lower risk of cognitive decline (OR=0.37, 95% C.I. 0.16-0.87) after controlling for age, gender, education, number of medical comorbidity, the presence of vascular risk factors/diseases, smoking, alcohol drinking, depression, APOE e4 allele carrier status, nutritional status, level of leisure activities, baseline MMSE and length of follow-up. The association remained significant (p=0.015) after excluding participants with baseline cognitive impairment (MMSE < 24), diabetes, stroke, and cardiac diseases (OR=0.23, 95% C.I. 0.07-0.75). No statistically significant association (OR=1.02, 95% C.I. 0.81-1.27) of fish consumption with cognitive decline was found. CONCLUSION: Daily n-3 PUFA supplements consumption was independently associated with less cognitive decline in elderly Chinese.
OBJECTIVE: To determine the association between long chain omega-3 polyunsaturated fatty acid (n-3 PUFA) supplements intake and cognitive decline in an older Chinese population. DESIGN: Prospective cohort study. SETTING: The Singapore Longitudinal Aging Studies (SLAS), a community-based study in urban region of Singapore. PARTICIPANTS: 1,475 Chinese adults aged ≥ 55 years. MEASUREMENT: Omega-3PUFA supplements intake and Mini-Mental State Examination (MMSE) were assessed at baseline. MMSE was re-assessed at a median of 1.5 years after baseline and cognitive decline was defined as at least 2-points drop in MMSE score from baseline to follow-up. Odds ratios (ORs) of association between n-3 PUFA supplements intake and cognitive decline were calculated in logistic regression models controlling for baseline confounding variables. RESULTS: Daily n-3 PUFA supplements intake was significantly (p=0.024) associated with lower risk of cognitive decline (OR=0.37, 95% C.I. 0.16-0.87) after controlling for age, gender, education, number of medical comorbidity, the presence of vascular risk factors/diseases, smoking, alcohol drinking, depression, APOE e4 allele carrier status, nutritional status, level of leisure activities, baseline MMSE and length of follow-up. The association remained significant (p=0.015) after excluding participants with baseline cognitive impairment (MMSE < 24), diabetes, stroke, and cardiac diseases (OR=0.23, 95% C.I. 0.07-0.75). No statistically significant association (OR=1.02, 95% C.I. 0.81-1.27) of fish consumption with cognitive decline was found. CONCLUSION: Daily n-3 PUFA supplements consumption was independently associated with less cognitive decline in elderly Chinese.
Authors: Martha Clare Morris; Denis A Evans; Julia L Bienias; Christine C Tangney; David A Bennett; Neelum Aggarwal; Julie Schneider; Robert S Wilson Journal: Arch Neurol Date: 2003-02
Authors: Nada A Abumrad; Daniele Piomelli; Karin Yurko-Mauro; Alfred Merrill; M Tom Clandinin; Charles N Serhan Journal: Adv Nutr Date: 2012-01-05 Impact factor: 8.701
Authors: Nicole L Cockayne; Shantel L Duffy; Rosalind Bonomally; Amelia English; Paul G Amminger; Andrew Mackinnon; Helen M Christensen; Sharon L Naismith; Ian B Hickie Journal: Trials Date: 2015-06-03 Impact factor: 2.279
Authors: Barbara J Meyer; Mitchell K Byrne; Carole Collier; Natalie Parletta; Donna Crawford; Pia C Winberg; David Webster; Karen Chapman; Gayle Thomas; Jean Dally; Marijka Batterham; Ian Farquhar; Anne-Marie Martin; Luke Grant Journal: PLoS One Date: 2015-03-20 Impact factor: 3.240
Authors: May A Beydoun; Hind A Beydoun; Alyssa A Gamaldo; Alison Teel; Alan B Zonderman; Youfa Wang Journal: BMC Public Health Date: 2014-06-24 Impact factor: 3.295
Authors: Andrew B Scholey; David A Camfield; Matthew E Hughes; Will Woods; Con K K Stough; David J White; Shakuntla V Gondalia; Pernille D Frederiksen Journal: Trials Date: 2013-11-26 Impact factor: 2.279